385 related articles for article (PubMed ID: 10449273)
1. AIDS vaccine research in Asia: needs and opportunities. Report from a UNAIDS/WHO/NIID meeting Tokyo, 28-30 October 1998.
AIDS; 1999 Jul; 13(11):UNAIDS 1-UNAIDS 13. PubMed ID: 10449273
[TBL] [Abstract][Full Text] [Related]
2. HIV gp120 vaccine - VaxGen: AIDSVAX, AIDSVAX B/B, AIDSVAX B/E, HIV gp120 vaccine - Genentech, HIV gp120 vaccine AIDSVAX - VaxGen, HIV vaccine AIDSVAX - VaxGen.
Adis International Ltd
Drugs R D; 2003; 4(4):249-53. PubMed ID: 12848591
[TBL] [Abstract][Full Text] [Related]
3. Future access to HIV vaccines. Report from a WHO-UNAIDS Consultation, Geneva, 2-3 October 2000.
AIDS; 2001 May; 15(7):W27-44. PubMed ID: 11399975
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 prophylactic vaccine trials in Thailand.
Pitisuttithum P
Curr HIV Res; 2005 Jan; 3(1):17-30. PubMed ID: 15638720
[TBL] [Abstract][Full Text] [Related]
5. Expanding research capacity and accelerating AIDS vaccine development in Asia.
Excler JL; Pitisuttithum P; Rerks-Ngarm S; Shao Y; Zhang L; Tamashiro H; Osmanov S;
Southeast Asian J Trop Med Public Health; 2008 Jul; 39(4):766-84. PubMed ID: 19058617
[TBL] [Abstract][Full Text] [Related]
6. Accelerating the development of an AIDS vaccine: the AIDS vaccine for Asia Network (Avan).
Pitisuttithum P; Rerks-Ngarm S; Chiu J; Kim J; Benenson M; Kent SJ; Tamashiro H; Manrique A; Bernstein A; Goyal R; Ditangco RA; Cooper DA; Osmanov S; Mathieson B; Sandstrom E; Esparza J; Hoff R; Shao Y;
Southeast Asian J Trop Med Public Health; 2011 Sep; 42(5):1130-46. PubMed ID: 22299439
[TBL] [Abstract][Full Text] [Related]
7. Recombinant bacillus Calmette-Guérin as a potential vector for preventive HIV type 1 vaccines.
Falk LA; Goldenthal KL; Esparza J; Aguado MT; Osmanov S; Ballou WR; Beddows S; Bhamarapravati N; Biberfeld G; Ferrari G; Hoft D; Honda M; Jackson A; Lu Y; Marchal G; McKinney J; Yamazaki S
AIDS Res Hum Retroviruses; 2000 Jan; 16(2):91-8. PubMed ID: 10659047
[TBL] [Abstract][Full Text] [Related]
8. Scientific considerations for the regulation and clinical evaluation of HIV/AIDS preventive vaccines: report from a WHO-UNAIDS Consultation 13-15 March 2001, Geneva, Switzerland.
AIDS; 2002 Jul; 16(10):W15-25. PubMed ID: 12131232
[TBL] [Abstract][Full Text] [Related]
9. Executive summary and recommendations from the WHO/UNAIDS/IAVI expert group consultation on 'Phase IIB-TOC trials as a novel strategy for evaluation of preventive HIV vaccines', 31 January-2 February 2006, IAVI, New York, USA.
WHO/UNAIDS/IAVI International Expert Group
AIDS; 2007 Feb; 21(4):539-46. PubMed ID: 17301582
[TBL] [Abstract][Full Text] [Related]
10. Defining the objectives of the AIDS vaccine for Asia network: report of the WHO-UNAIDS/Global HIV vaccine enterprise regional consultation on expanding AIDS vaccine research and development capacity in Asia.
Rerks-Ngarm S; Pitisuttithum P; Ganguly N; Zhang L; Tamashiro H; Cooper DA; Vun MC; Bela B; Ditangco R; Van Kinh N; Bernstein A; Osmanov S; Mathieson B; Kent SJ; Shao Y
Curr Opin HIV AIDS; 2010 Sep; 5(5):435-52. PubMed ID: 20978386
[No Abstract] [Full Text] [Related]
11. India to develop its own AIDS vaccine.
Jayaraman KS
Nat Med; 1998 Jan; 4(1):7. PubMed ID: 9427585
[TBL] [Abstract][Full Text] [Related]
12. An HIV vaccine: how and when?
Esparza J
Bull World Health Organ; 2001; 79(12):1133-7. PubMed ID: 11799445
[TBL] [Abstract][Full Text] [Related]
13. Executive summary and recommendations from WHO/UNAIDS and AAVP consultation on: 'The inclusion of adolescents in HIV vaccine trials', 16-18 March 2006 in Gaborone, Botswana.
; Osmanov S
AIDS; 2007 Sep; 21(14):W1-10. PubMed ID: 17721089
[TBL] [Abstract][Full Text] [Related]
14. Grappling with global concerns in the search for an HIV vaccine.
Grady C
J Assoc Nurses AIDS Care; 1999; 10(1):17-20. PubMed ID: 9934666
[TBL] [Abstract][Full Text] [Related]
15. Public health considerations for the use of a first generation HIV vaccine. Report from a WHO-UNAIDS-CDC consultation, Geneva, 20-21 November 2002.
Chang ML; Vitek C; Esparza J;
AIDS; 2003 Oct; 17(15):W1-10. PubMed ID: 14523295
[TBL] [Abstract][Full Text] [Related]
16. Ethical considerations in international HIV vaccine trials: summary of a consultative process conducted by the Joint United Nations Programme on HIV/AIDS (UNAIDS).
Guenter D; Esparza J; Macklin R
J Med Ethics; 2000 Feb; 26(1):37-43. PubMed ID: 10701170
[TBL] [Abstract][Full Text] [Related]
17. Convergent ethical issues in HIV/AIDS, tuberculosis and malaria vaccine trials in Africa: Report from the WHO/UNAIDS African AIDS Vaccine Programme's Ethics, Law and Human Rights Collaborating Centre consultation, 10-11 February 2009, Durban, South Africa.
Mamotte N; Wassenaar D; Koen J; Essack Z
BMC Med Ethics; 2010 Mar; 11():3. PubMed ID: 20211030
[TBL] [Abstract][Full Text] [Related]
18. HIV vaccine research in Thailand: lessons learned.
Pitisuttithum P
Expert Rev Vaccines; 2008 Apr; 7(3):311-7. PubMed ID: 18393601
[TBL] [Abstract][Full Text] [Related]
19. Foundations for a Phase III human immunodeficiency virus vaccine trial: A decade of Thai-U.S. Army collaborative research.
Brown AE; Nitayaphan S
Mil Med; 2004 Aug; 169(8):588-93. PubMed ID: 15379068
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of HIV and AIDS in the Asia-Pacific region.
Dore GJ; Kaldor JM; Ungchusak K; Mertens TE
Med J Aust; 1996 Nov; 165(9):494-8. PubMed ID: 8937371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
